title: Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C.
authors.affiliation: Division of Hematology & Medical Oncology, New York University School of Medicine, Laura and Isaac Perlmutter Cancer Center, New York, NY, USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Lin
authors.affiliation: Division of Hematology & Medical Oncology, New York University School of Medicine, Laura and Isaac Perlmutter Cancer Center, New York, NY, USA.
authors.forename: T
authors.initials: T
authors.lastname: Moskovits
authors.affiliation: Division of Hematology & Medical Oncology, New York University School of Medicine, Laura and Isaac Perlmutter Cancer Center, New York, NY, USA.
authors.forename: C S
authors.initials: CS
authors.lastname: Diefenbach
authors.affiliation: Division of Hematology & Medical Oncology, New York University School of Medicine, Laura and Isaac Perlmutter Cancer Center, New York, NY, USA.
authors.forename: K B
authors.initials: KB
authors.lastname: Hymes
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018450:Disease Progression; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D000069474:Sofosbuvir / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000069474:Sofosbuvir